RxDoctor Payments Data

Joseph Costa, DO

Urology · Jacksonville, FLNPI 1467424093

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,253 of the $6,647 with a category attached, or 79.0%. 19 manufacturers reported payments, led by Coloplast at 46.7% of the total.

$6,647in general payments, 2019–2025

Across 72 payments — averaging $92.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$3K
  • Boston Scientific$838
  • Medtronic$336
  • Ambu Inc.$330
  • Teleflex LLC$285
  • Axonics, Inc.$193
  • plus $2K from 13 others
$52,956in research payments, 2019–2025

Across 19 payments — averaging $2787.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sumitomo Pharma America, Inc.$53K

What the payments were for

  • Travel & lodging$1,05016%
  • Food & beverage$5,25379%
  • Education$3445%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,647 in reported general payments places this provider in the 65th percentile of 935 urology providers in Florida.

See all urology providers in Florida →

Medicare billing

Part B allowed, 2024
$85,386
Medicare patients
230
Services billed
725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron12$6,204
Solifenacin Succinate43$1,871
Estradiol14$1,231
Oxybutynin Chloride ErOxybutynin Chloride15$280
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$150
Tamsulosin Hcl22$126

Paid to pharmacies, not to this prescriber.

Other urology in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →